Core Viewpoint - Globe Life Inc. (GL) has shown strong performance in the life and health insurance sector, with a market cap of $11.3 billion and a focus on lower middle- and middle-income families [1]. Financial Performance - In Q4 2025, Globe Life reported adjusted EPS of $3.39 and revenue of $1.52 billion, which were weaker than expected; however, shares rose 1.5% the following day due to strong year-over-year gains [4]. - For the fiscal year ending December 2026, analysts expect GL's adjusted EPS to grow 4.1% year-over-year to $15.12 [5]. Stock Performance - Over the past 52 weeks, GL stock has increased by 16.1%, outperforming the S&P 500 Index's 14.4% gain [2]. - Year-to-date, GL stock is up 1.5%, slightly ahead of the S&P 500's 1.4% gain [2]. Analyst Ratings - Among 14 analysts covering Globe Life, the consensus rating is a "Moderate Buy," with eight "Strong Buys," one "Moderate Buy," and five "Holds" [5]. - J.P. Morgan's Jimmy Bhullar reaffirmed a "Buy" rating with a price target of $181, while the mean price target of $169.50 suggests a 19.4% premium to current levels [6].

Core Insights - CNO Financial Group, Inc. (CNO) is well-positioned for growth, driven by strong collected premiums from annuity, life, and health products, along with rising new annualized premiums and higher fee revenues [1] - CNO's shares have increased by 14.4% over the past year, outperforming the industry growth of 6.6% [1] Company Overview - CNO Financial, headquartered in Carmel, IN, has a market capitalization of $3.8 billion and offers a range of insurance and financial services products [2] - The company's forward 12-month P/E ratio is 9.50X, higher than the industry average of 8.86X [2] - CNO currently holds a Zacks Rank 3 (Hold) due to solid growth prospects [2] Financial Estimates - The Zacks Consensus Estimate for CNO's 2025 earnings is $3.79 per share, with revenues expected to reach $3.9 billion [3] - CNO has beaten earnings estimates in three of the past four quarters, with an average surprise of 14.2% [3] Growth Drivers - CNO's diversified product portfolio, including annuity, health, and life insurance, allows effective risk management and a steady stream of premium income [4] - Total collected premiums increased by 8.7% year over year in Q2 2025, with total insurance policy income growing by 1.5% [5] - Policyholder and other special-purpose portfolios surged by 83.6% year over year in Q2 2025 [5] Strategic Initiatives - CNO is focused on launching innovative products and enhancing existing offerings to capture future insurance premium growth [6] - The company is leveraging acquisitions and partnerships to diversify its portfolio and expand its geographic presence [6] - Continuous investment in technology aims to boost agent productivity and enhance sales and marketing efficiency [7] Shareholder Returns - CNO has shown a strong commitment to shareholder returns, repurchasing $100 million worth of shares and paying $16.7 million in dividends in Q2 2025 [8]